The arrival of Retatrutide in the United Kingdom is creating significant anticipation within the weight management community. This innovative dual agonist – targeting both GLP-1 and GIP – suggests a significantly new approach to combating excess weight . Currently , options have been limited for many, and Retatrutide embodies a promising possib